μμνΈλ ν΄
**μμνΈλ ν΄(Acitretin)**μ 2μΈλ μ μ μ± λ ν°λ Έμ΄λμ΄λ©° μνΈλ ν°λ€μ΄νΈμ νμ± λμ¬ μ°λ¬Όμ λλ€. * μ£Όλ‘ μμ νΌλΆκ³Όμμ μ€μ¦μ κ°ν μ΄μ, νΌμ§μ μ΄μ λ° νΉμ νΌλΆ μ’ μμ κ΄λ¦¬νλ λ° μ¬μ©λ©λλ€. * λ°κ°κΈ°κ° νμ ν μ§§μ μ‘°μ§ μΆμ κΈ°κ°κ³Ό μ΄λ‘ μΈν μ₯κΈ° λ μ±μ μ€μ¬μ£ΌκΈ° λλ¬Έμ μΈμ²΄ μμ₯μμ μνΈλ ν°λ€μ΄νΈλ₯Ό λ체νμ΅λλ€. * **μμ μμ **: κ°μ μΈ΅νμ λΉλμ¦, νΌμ§μ μΌ λ° νλΉμΌλ‘ μΈν μ μμ± λ³λ³κ³Ό κ°μ μ§νμ λ§€μ° ν¨κ³Όμ μ΄μ§λ§, μμνμμμ μ¬μ©μ λμ λΉμ©, κΈ°ν μ λ° μν λ° μν νμμκ² μ νν μ©λμ ν¬μ¬νκΈ° μν μ‘°μ μ νμμ± λλ¬Έμ μ’ μ’ μ νλ©λλ€.
μμ© κΈ°μ : Acitretin works by interacting with intracellular receptors to modulate cellular differentiation and proliferation. * Binds to nuclear **Retinoic Acid Receptors (RARs)** and **Retinoid X Receptors (RXRs)**. * Receptor-ligand complexes bind to specific DNA sequences β **alters gene transcription**. * **Pharmacodynamic Effects**: Normalizes keratinocyte differentiation, reduces epidermal hyperproliferation, decreases sebum production, and exerts anti-inflammatory and antineoplastic effects (particularly against squamous cell carcinomas).
λλ¬Ό μ’ λ³ μ©λ
- Actinic keratosis/solar-induced squamous cell carcinoma; or Bowen's Disease Β· 10 mg per cat Β· PO Β· once daily Β· Note: This dose is for etretinate, but as the smallest capsule is 10 mg, this dose may need to suffice as well for cats.
- Bowen's Disease Β· 3 mg/kg/day Β· PO Β· once daily
- Dermatologic conditions where retinoids may be useful Β· 0.5-1 mg/kg Β· PO Β· once daily
- Dermatologic conditions where retinoids may be useful Β· 0.5-2 mg/kg Β· PO Β· once daily
- Sebaceous adenitis Β· 0.5-1 mg/kg Β· PO Β· once daily
μ©λμ λ©΄ν μμ μ λ¬Έκ°λ₯Ό μν μμ μ°Έκ³ μλ£μ λλ€. νμ μ΅μ λΌλ²¨κ³Ό κ°λ³ νμμ λν΄ νμΈνμμμ€.
ν¬μ¬ κ²½λ‘
κΈκΈ°
- Pregnancy (absolute contraindication)
- Cardiovascular disease
- Hypertriglyceridemia
- Known sensitivity to acitretin or other retinoids
μ΄μλ°μ
- Anorexia
- Vomiting
- Diarrhea
- Cracking of foot pads
- Pruritus
- Ventral abdominal erythema
- Polydipsia
- Lassitude
- Joint pain/stiffness
- Eyelid abnormalities
- Keratoconjunctivitis sicca (KCS)
- Swollen tongue
- Behavioral changes
- Weight loss (especially in cats)
μ½λ¬Ό μνΈμμ©
- Alcohol Β· Acitretin can form etretinate in the presence of alcohol; etretinate is a teratogen with an extremely long terminal half-life that can persist in adipose tissue for years.
- Hepatotoxic drugs (e.g., methotrexate, ketoconazole, sulfonamides, fluconazole, macrolides) Β· May increase the potential for hepatotoxicity.
- Other retinoids (isotretinoin, tretinoin, vitamin A) Β· May cause additive toxic effects.
- Tetracyclines Β· May increase the potential for the occurrence of pseudotumor cerebri (cerebral edema and increased CSF pressure).
λͺ¨λν°λ§
- Clinical efficacy
- Liver function tests (baseline and if clinical signs appear)
- Schirmer tear tests (monthly, especially in older dogs)
- Serum triglycerides and cholesterol (recommended based on human data)
κ³Όμ©λ
Information on overdoses with this agent remains limited. One oral overdose (525 mg) in a human patient resulted only in vomiting. The oral LD50 in rats and mice is >4 grams/kg.
VetSheet μ½λ¬Ό λ νΌλ°μ€λ λ©΄ν μμ μ λ¬Έκ°λ₯Ό μν μμ μμ¬κ²°μ 보쑰 λꡬμ΄λ©°, μ λ¬Έμ νλ¨μ΄λ μ μ‘°μ¬μ μ΅μ λΌλ²¨μ λμ νμ§ μμ΅λλ€.